Implantation or Injectable Dosage Form New Animal Drugs; Naltrexone Hydrochloride Injection
other · US Department of Health and Human Services · Rule · Published 1997-02-05 · Effective 1997-02-05 · 62 FR 5319
Document
Document number
97-2869
Federal Register citation
62 FR 5319
CFR reference
21 CFR 522
Type
Rule
Action
Final rule.
Category
other
Sub-agency
US Department of Health and Human Services
Publication date
1997-02-05
Effective date
1997-02-05
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Wildlife Laboratories, Inc. The NADA provides for use of naltrexone hydrochloride sterile injection as an antagonist to carfentanil citrate immobilization in free-ranging or confined elk and moose (Cervidae).